Please ensure Javascript is enabled for purposes of website accessibility

Corporation for Public Broadcasting to Close After Funding Cut, in Blow to Local Media

2 days ago

‘Freedom Week’: California Gun Owners Rush to Buy Ammo After Court Ruling

2 days ago

Wall Street Selloff Sparked by Trump Tariffs, Amazon Results, Weak Payrolls

2 days ago

US Construction Spending Extends Decline in June

2 days ago

Global Shares in Red After US Jobs Data, Trump’s Tariff Salvo

2 days ago

Construction of $200M Trump Ballroom at the White House to Begin in September

3 days ago

US Senate Committee Backs $1 Billion for Ukraine in Pentagon Spending Bill

3 days ago

Trump Says Mexico Trade Deal Extended for 90 Days

3 days ago

Fresno Unified Trustee Susan Wittrup Responds to $162,000 Payout

4 days ago
Experts Scramble, but New Virus Vaccine May Not Come in Time
gvw_ap_news
By Associated Press
Published 5 years ago on
February 7, 2020

Share

WASHINGTON — The flu-like virus that exploded from China has researchers worldwide once again scrambling to find a vaccine against a surprise health threat, with no guarantee one will arrive in time.
Just days after Chinese scientists shared the genetic map of the culprit coronavirus, researchers at the U.S. National Institutes of Health had engineered a possible key ingredient for a vaccine they hope to begin testing by April.
Scientists from Australia to France, along with a list of biotech and vaccine companies, jumped in the race, pursuing different types of inoculations.

“We have the technology now. It’s feasible from an engineering and biological standpoint.” Dr. Barney Graham, deputy director of the National Institute of Allergy and Infectious Diseases’ Vaccine Research Center
And Texas researchers froze an experimental vaccine developed too late to fight an earlier coronavirus — SARS, or severe acute respiratory syndrome — but are pushing U.S. and Chinese authorities to give it a try this time around. Because the new virus is a close cousin of SARS, it just might protect, said Dr. Peter Hotez of Baylor College of Medicine and Texas Children’s Hospital.
All that work is coming at lightning speed compared to past outbreaks. Yet many experts agree it still may take a year — if every step along the way goes well — for any vaccine to be ready for widespread use. That’s if it’s even needed by then.
Globally, more than 28,000 people are infected and the death toll climbed past 560. The overwhelming majority are in China, but more than 200 people with the illness have been reported in over two dozen other countries.
For now, health officials are isolating the sick to fight spread of the virus, which causes fever, cough and in severe cases pneumonia. With no specific treatment, some doctors also are experimenting with antiviral medicines developed for other conditions.
“Ours is already manufactured and could take off pretty quickly,” said Hotez, who created the earlier SARS vaccine with Texas Children’s colleague Maria Elena Bottazzi. But “there’s still no road map for what you do to make a vaccine in the midst of a devastating public health outbreak.”
NIH specialists say rather than chasing outbreaks, it’s time to pursue prototype vaccine designs that could work for entire virus families, ready to be pulled off the shelf at the first sign of a new disease.
“We have the technology now. It’s feasible from an engineering and biological standpoint,” said Dr. Barney Graham, deputy director of the National Institute of Allergy and Infectious Diseases’ Vaccine Research Center. Without that step, “we’re going to be at risk for new pandemics.”
Photo of Pasteur Institute in Paris
View of the logo at Pasteur Institute in Paris, Thursday, Feb. 6, 2020. Scientists at the Pasteur Institute developed and shared a quick test for the new virus that is spreading worldwide, and are using genetic information about the coronavirus to develop a potential vaccine and treatments. (AP Photo/Francois Mori)

A Faster Vaccine Recipe

Traditionally, making vaccines required first growing lots of virus in a lab. The NIH team is pursuing a newer and far faster method: Simply use a piece of the virus’ genetic code, called messenger RNA or mRNA, that instructs cells to make a particular protein.
“We think of RNA as the software of life,” said Dr. Tal Zaks, chief medical officer of Moderna Inc., which is developing mRNA vaccines for other diseases and working with NIH on the new coronavirus.
Inject the right piece and “you’ve taught the body to make its own medicine,” he explained. As cells produce just that protein, the immune system learns to recognize it, primed to attack if the entire virus ever comes along.
The target: A protein aptly named “spike” that lets the virus bind to cells. It studs the surface of coronaviruses — the new one as well as its cousins SARS, which erupted in China in 2002 and spread to 26 countries, and MERS, or Middle East respiratory syndrome, which emerged in 2012.
Graham’s team zeroed in on the RNA responsible for the new virus’ production of spike and then — because prior research showed the protein can change shape — engineered a more stable version of it.
Moderna is manufacturing samples of the synthetic mRNA vaccine for NIH to use in animal studies and, hopefully within three months, first-stage safety tests in people. If further testing proves it really works, the hope is scientists could simply swap in a new spike code if another coronavirus comes along.
That’s important because after three such outbreaks in less than 20 years, “this is not the last,” predicted Dr. Mark Denison, a virologist at Vanderbilt University Medical Center. It’s key to find vaccine “strategies that go after these unique things common to every coronavirus.”

What Else Is in the Pipeline

Inovio Pharmaceuticals is pursuing a similar approach with synthetic DNA, and recently reported promising results from first-stage testing of a MERS vaccine. It’s collaborating with a Chinese company, Beijing Advaccine, in hopes of being able to test a new vaccine candidate in China later this year.

“The work we’re doing now involves making a vaccine against measles but re-engineered in the sense that it has antigens from the new coronavirus.” virologist Frederic Tangy, head of Pasteur’s vaccine innovation department
In France, researchers at the Pasteur Institute are piggybacking on the tried-and-true vaccine against measles. They’ve had some early success mixing genetic material from other viruses into that vaccine, and now hope to put the immune system on alert against this new coronavirus in the same way.
“The work we’re doing now involves making a vaccine against measles but re-engineered in the sense that it has antigens from the new coronavirus,” said virologist Frederic Tangy, head of Pasteur’s vaccine innovation department.
What about Hotez’s old SARS vaccine? In that case a piece of the spike protein was genetically engineered and grown in a lab, a classic vaccine technology compared to the newer and less proven Moderna and Inovio approaches. The Texas researchers showed the vaccine protected animals but in 2016 ran out of money for further testing and froze what was left. Every six months, Hotez thaws a small sample to make sure it’s still usable.
Photo of a scientist holding samples
Vincent Enouf, Deputy director of National Flu Center displays samples prior to put them into machine for analyze at Pasteur Institute in Paris, Thursday, Feb. 6, 2020. Scientists at the Pasteur Institute developed and shared a quick test for the new virus that is spreading worldwide, and are using genetic information about the coronavirus to develop a potential vaccine and treatments. (AP Photo/Francois Mori)French lab scientist in hazmat gear inserting liquid in test tube

Chasing Outbreaks

Past outbreaks are full of such missed opportunities: There’s no commercial vaccine for MERS even though illnesses still occur. The birth defect-causing Zika outbreak was ending by the time experimental shots were ready to test.
The bright spot: Ebola vaccines. Some candidates began early testing during the massive Ebola epidemic in West Africa in 2014-2016, although the outbreak waned before scientists had proof they worked. But authorities and vaccine companies kept up the research, and by 2018 shots were ready to help tamp down an outbreak still smoldering in Congo.
The World Health Organization will meet next week to identify promising drug and vaccine candidates for the new coronavirus and fast-track their development, much like happened with Ebola.
“To put it bluntly, we’re shadow boxing,” said WHO Director-General Tedros Adhanom Ghebreyesus. “We need to bring this shadow out into the light so that we can attack it properly.”

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Iran’s Army Chief Says Israeli Threats Remain, State Media Say

DON'T MISS

Tens of Thousands Join Pro-Palestinian March Over Sydney Harbour Bridge

DON'T MISS

Trump, Carney to Speak in Coming Days, Canadian Official Says

DON'T MISS

Rail Customers Urge Regulators to Block Union Pacific-Norfolk Southern Deal, FT Reports

DON'T MISS

United States Set World Record in Women’s 4×100 Medley Relay

DON'T MISS

White House Backs Away From IVF Coverage Mandate Despite Trump’s Campaign Pledge, Washington Post Reports

DON'T MISS

Six More Die of Hunger in Gaza, Israel Says UN Trucks Make Fuel Delivery

DON'T MISS

Gifford Fire Grows to Nearly 40,000 Acres. Evacuation Orders Expanded in Santa Barbara, San Luis Obispo Counties

DON'T MISS

This Test Can See a Heart Attack in Your Future

DON'T MISS

‘South Park’ Skewers a New Kind of Sanctimony and Trump

UP NEXT

Tens of Thousands Join Pro-Palestinian March Over Sydney Harbour Bridge

UP NEXT

Trump, Carney to Speak in Coming Days, Canadian Official Says

UP NEXT

Rail Customers Urge Regulators to Block Union Pacific-Norfolk Southern Deal, FT Reports

UP NEXT

United States Set World Record in Women’s 4×100 Medley Relay

UP NEXT

White House Backs Away From IVF Coverage Mandate Despite Trump’s Campaign Pledge, Washington Post Reports

UP NEXT

Six More Die of Hunger in Gaza, Israel Says UN Trucks Make Fuel Delivery

UP NEXT

India Will Buy Russian Oil Despite Trump’s Threats, Officials Say

UP NEXT

The US Said It Had No Choice but to Deport Them to a Third Country. Then It Sent Them Home

UP NEXT

Trump Reaffirms Support for Morocco’s Sovereignty Over Western Sahara

UP NEXT

Kia America Recalls 201,149 US Telluride Vehicles

Rail Customers Urge Regulators to Block Union Pacific-Norfolk Southern Deal, FT Reports

4 hours ago

United States Set World Record in Women’s 4×100 Medley Relay

4 hours ago

White House Backs Away From IVF Coverage Mandate Despite Trump’s Campaign Pledge, Washington Post Reports

4 hours ago

Six More Die of Hunger in Gaza, Israel Says UN Trucks Make Fuel Delivery

4 hours ago

Gifford Fire Grows to Nearly 40,000 Acres. Evacuation Orders Expanded in Santa Barbara, San Luis Obispo Counties

4 hours ago

This Test Can See a Heart Attack in Your Future

6 hours ago

‘South Park’ Skewers a New Kind of Sanctimony and Trump

6 hours ago

India Will Buy Russian Oil Despite Trump’s Threats, Officials Say

1 day ago

The US Said It Had No Choice but to Deport Them to a Third Country. Then It Sent Them Home

1 day ago

Trump Reaffirms Support for Morocco’s Sovereignty Over Western Sahara

1 day ago

Iran’s Army Chief Says Israeli Threats Remain, State Media Say

DUBAI — The commander-in-chief of Iran’s military, Amir Hatami, said on Sunday that threats from Israel persist, according to state me...

3 hours ago

Iranian Army commander-in-chief Amir Hatami attends a meeting in the Iranian Army's War Command Room at an undisclosed location in Iran, in this handout image obtained on June 23, 2025. (Reuters File)
3 hours ago

Iran’s Army Chief Says Israeli Threats Remain, State Media Say

Protesters walk across the Sydney Harbour Bridge during the Palestine Action Group's March for Humanity in Sydney, Australia, August 3, 2025. AAP/Dean Lewins via REUTERS
3 hours ago

Tens of Thousands Join Pro-Palestinian March Over Sydney Harbour Bridge

Canada's Prime Minister Mark Carney arrives at a press conference to make an announcement on recognizing Palestinian statehood, in Ottawa, Ontario, Canada, July 30, 2025. (Reuters File)
4 hours ago

Trump, Carney to Speak in Coming Days, Canadian Official Says

A Union Pacific rail car is parked at a Burlington Northern Santa Fe (BNSF) train yard in Seattle, Washington, U.S., February 10, 2017. (Reuters File)
4 hours ago

Rail Customers Urge Regulators to Block Union Pacific-Norfolk Southern Deal, FT Reports

World Aquatics Championships - Women 4x100m Medley Relay Final - World Aquatics Championships Arena, Singapore - August 3, 2025 Regan Smith, Kate Douglass, Gretchen Walsh and Torri Huske of the U.S. celebrate after winning the final and making a new world record REUTERS/Edgar Su
4 hours ago

United States Set World Record in Women’s 4×100 Medley Relay

A view shows Alabama Fertility, an IVF clinic in Birmingham, Alabama, U.S., February, 23, 2024. (Reuters File)
4 hours ago

White House Backs Away From IVF Coverage Mandate Despite Trump’s Campaign Pledge, Washington Post Reports

4 hours ago

Six More Die of Hunger in Gaza, Israel Says UN Trucks Make Fuel Delivery

The Gifford Fire has scorched nearly 40,000 acres in Santa Barbara and San Luis Obispo counties as of Sunday, August 3, 2025, prompting multiple evacuation orders and the closure of Highway 166 as crews work to contain the fast-moving wildfire. (CalFire)
4 hours ago

Gifford Fire Grows to Nearly 40,000 Acres. Evacuation Orders Expanded in Santa Barbara, San Luis Obispo Counties

Help continue the work that gets you the news that matters most.

Search

Send this to a friend